Pirfenidone Capsule
Product Images NDC 50228-441

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Pirfenidone (NDC 50228-441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Pirfenidone 02)

Figure 1 (Pirfenidone 02)
The text appears to be a chart or a table showing the percentage of patients on Pirfenidone and Placebo with worsening or no decline in %FVC (Forced Vital Capacity) after 52 weeks of treatment. It also includes the absolute change in %FVC from baseline. However, the data is not presented clearly and it is difficult to interpret the results without additional information.*
FDA Label Image

Figure 2 (Pirfenidone 03)

FDA Label Image

Figure 3 (Pirfenidone 04)

Figure 3 (Pirfenidone 04)
This appears to be a statistical analysis of a drug called Prednisone versus placebo, conducted on a sample of 623 people. However, the text is not complete and difficult to interpret out of context. A visual representation may help to better understand the data.*
FDA Label Image

Principal Display Panel (267 mg 30 Capsules)

FDA Label Image

Principal Display Panel (267 mg 500 Capsules)

Principal Display Panel (267 mg 500 Capsules)
This is a description of a medication called Pirfenidone, contained in capsules of 267 mg. The recommended dosage and storage instructions can be found in the package insert. The medication should be stored at a controlled room temperature of 25°C with excursions permitted between 15° and 30°C. The NDC code is 50228-441-05 and the medication is manufactured by ScieGen Pharmaceuticals in Hauppauge, NY. The medication should be kept out of reach of children. The medication is only available with a prescription. The expiration date is indicated as "NO VARNISH" and there is also a barcode on the package.*
FDA Label Image

Chemical Structure (Pirfenidone Str 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.